Comments on the article “Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study”

被引：0
|
作者：
Thuy Nhu Thai
Ghadeer K. Dawwas
机构：
[1] University of Florida,Department of Pharmaceutical Outcomes and Policy, College of Pharmacy
来源：
Arthritis Research & Therapy | / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] DIRECT COMPARISON OF EFFECTIVENESS AND SAFETY OF TOFACITINIB AND BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL-WORLD SETTINGS
    Iwamoto, N.
    Suzuki, T.
    Okada, A.
    Fujikawa, K.
    Aramaki, T.
    Mizokami, A.
    Ueki, Y.
    Kawakami, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 581 - 581
  • [32] Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
    Megan E. B. Clowse
    Steven R. Feldman
    John D. Isaacs
    Alexandra B. Kimball
    Vibeke Strand
    Richard B. Warren
    Daniel Xibillé
    Yan Chen
    Donald Frazier
    Jamie Geier
    James Proulx
    Amy Marren
    [J]. Drug Safety, 2016, 39 : 755 - 762
  • [33] Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
    Clowse, Megan E. B.
    Feldman, Steven R.
    Isaacs, John D.
    Kimball, Alexandra B.
    Strand, Vibeke
    Warren, Richard B.
    Xibille, Daniel
    Chen, Yan
    Frazier, Donald
    Geier, Jamie
    Proulx, James
    Marren, Amy
    [J]. DRUG SAFETY, 2016, 39 (08) : 755 - 762
  • [34] EFFECTIVENESS, TOLERABILITY, AND SAFETY OF TOFACITINIB IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE ANALYSIS OF REAL-WORLD DATA FROM THE ST. GALLEN AND AARAU COHORT
    Mueller, R.
    Popp, F.
    Mattowl, F.
    Durmisi, M.
    Souza, A.
    Schulze-Koops, H.
    Hasler, P.
    von Kempis, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1409 - 1409
  • [35] THE EFFICACY AND SAFETY OF TOFACITINIB IN THE TREATMENT OF DMARDS NAIVE RHEUMATOID ARTHRITIS PATIENTS (EASTERN STUDY)
    Zhao, J.
    Wang, Y.
    Zhang, Z.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1441 - 1441
  • [36] Time to Discontinuation of Tofacitinib in Rheumatoid Arthritis Patients with and Without Methotrexate: Results from a Rheumatoid Arthritis Cohort
    Movahedi, Mohammad
    Cesta, Angela
    Li, Xiuying
    Keystone, Edward
    Bombardier, Claire
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [37] Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia
    Deakin, Claire T.
    De Stavola, Bianca L.
    Littlejohn, Geoffrey
    Griffiths, Hedley
    Ciciriello, Sabina
    Youssef, Peter
    Mathers, David
    Bird, Paul
    Smith, Tegan
    O'Sullivan, Catherine
    Freeman, Tim
    Segelov, Dana
    Hoffman, David
    Seaman, Shaun R.
    [J]. JAMA NETWORK OPEN, 2023, 6 (06) : E2320851
  • [38] Tofacitinib: A Review in Rheumatoid Arthritis
    Sohita Dhillon
    [J]. Drugs, 2017, 77 : 1987 - 2001
  • [39] Tofacitinib for Treatment of Rheumatoid Arthritis
    Rakieh, Chadi
    Conaghan, Philip G.
    [J]. ADVANCES IN THERAPY, 2013, 30 (08) : 713 - 726
  • [40] Tofacitinib: A Review in Rheumatoid Arthritis
    Dhillon, Sohita
    [J]. DRUGS, 2017, 77 (18) : 1987 - 2001
12345